The WHO suggestions encourage the adoption of such technologies, delivered they can be validated to exhibit equivalent or exceptional general performance when compared to conventional approaches. Manufacturers trying to employ these strategies must give sturdy validation knowledge to display their equivalence to pharmacopoeial solutions. Be it an issue of waiting for link from Forum Profiles (11)